Seminars in Oncology Nursing
Volume 23, Issue 2 , Pages 127-135 , May 2007

Fatigue, Depression, and Insomnia: Evidence for a Symptom Cluster in Cancer

  • Kristine A. Donovan

      Affiliations

    • Corresponding Author InformationAddress correspondence to Kristine A. Donovan, PhD, Health Outcomes and Behavior Program, H. Lee Moffitt Cancer Center & Research Institute, 12902 Magnolia Dr, MRC-PSY, Tampa, FL 33612
    • ,
  • Paul B. Jacobsen

References 

  1. Dodd MJ, Miaskowski C, Paul SM. Symptom clusters and their effect on the functional status of patients with cancer. Oncol Nurs Forum. 2001;28:465–470
  2. McNair DM, Lorr M, Doppleman LF. Profile of Mood States Manual. San Diego, CA: Educational and Industrial Testing Service; 1971;
  3. McCorkle R, Young K. Development of a symptom distress scale. Cancer Nurs. 1978;1:373–378
  4. Beck AT, Ward CH, Mendelson M, et al. An inventory for measuring depression. Arch Gen Psychiatry. 1961;4:53–63
  5. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Applied Psychol Meas. 1977;1:385–401
  6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: American Psychiatric Press; 1994;
  7. Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psych Res. 1989;28:193–213
  8. Morin CM. Insomnia: Psychological Assessment and Management. New York: The Guilford Press; 1993;
  9. Savard MH, Savard J, Simard S, et al. Empirical validation of the Insomnia Severity Index in cancer patients. Psychooncol. 2005;14:429–441
  10. American Sleep Disorders Association. The International Classification of Sleep Disorders. Diagnostic and Coding Manual. Rochester, NY: American Sleep Disorders Association; 1997;
  11. Cella D, Peterman A, Passik S, et al. Progress toward guidelines for the management of fatigue. Oncology. 1998;12:369–377
  12. Smets EMA, Garssen B, Cull A, et al. Application of the Multidimensional Fatigue Inventory (MFI-20) in cancer patients receiving chemotherapy. Br J Cancer. 1996;73:241–245
  13. Stein KD, Martin SC, Hann DM, et al. A multidimensional measure of fatigue for use with cancer patients. Cancer Pract. 1998;6:143–152
  14. Lawrence DP, Kupelnick B, Miller K, et al. Evidence report on the occurrence, assessment, and treatment of fatigue in cancer patients. J Natl Cancer Inst Monogr. 2004;32:40–50
  15. Ahlberg K, Ekman T, Gaston-Johansson F, et al. Assessment and management of cancer-related fatigue in adults. Lancet. 2003;362:640–650
  16. Pirl W. Evidence report on the occurrence, assessment, and treatment of depression in cancer patients. J Natl Cancer Inst Monogr. 2004;32:32–39
  17. Massie MJ. Prevalence of depression in patients with cancer. J Natl Cancer Inst Monogr. 2004;32:57–71
  18. Savard J, Morin MC. Insomnia in the context of cancer: a review of a neglected problem. J Clin Oncol. 2001;19:895–908
  19. Savard J, Simard S, Hervouet S, et al. Insomnia in men treated with radical prostatectomy for prostate cancer. Psychooncol. 2005;14:147–156
  20. Savard J, Simard S, Blanchet J, et al. Prevalence, clinical characteristics, and risk factors for insomnia in the context of breast cancer. Sleep. 2001;24:583–590
  21. Andrykowski MA, Curran SL, Lightner R. Off-treatment fatigue in breast cancer survivors: a controlled comparison. J Behav Med. 1998;21:1–18
  22. Broeckel JA, Jacobsen PB, Horton J, et al. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol. 1998;16:1689–1696
  23. Carpenter JS, Andrykowski MA. Psychometric evaluation of the Pittsburgh Sleep Quality Index. J Psychosom Res. 1998;45:5–13
  24. Carpenter JR, Elam JL, Ridner SH, et al. Sleep, fatigue, and depressive symptoms in breast cancer survivors and matched healthy women experiencing hot flashes. Oncol Nurs Forum. 2004;31:591–598
  25. Fillion L, Gelinas C, Simard S, et al. Validation evidence for the French Canadian adaptation of the Multidimensional Fatigue Inventory as a measure of cancer-related fatigue. Cancer Nurs. 2003;26:143–153
  26. Hann DM, Jacobsen PB, Martin SC, et al. Fatigue in women treated with bone marrow transplantation for breast cancer: a comparison with women with no history of cancer. Support Care Cancer. 1997;5:44–52
  27. Hwang SS, Chang VT, Kasimis BS. A comparison of three fatigue measures in veterans with cancer. Cancer Invest. 2003;21:363–373
  28. Mock V, Dow KH, Meares CJ, et al. Effects of exercise on fatigue, physical functioning, and emotional distress during radiation therapy for breast cancer. Oncol Nurs Forum. 1997;24:991–1000
  29. Okuyama T, Akechi T, Kugaya A, et al. Factors correlated with fatigue in disease-free breast cancer patients: application of the Cancer Fatigue Scale. Support Care Cancer. 2000;8:215–222
  30. Redeker NS, Lev EL, Ruggiero J. Insomnia, fatigue, anxiety, depression, and quality of life of cancer patients undergoing chemotherapy. Sch Inq Nurs Pract. 2000;14:275–290
  31. Smets EMA, Visser M, Willems-Groot AF, et al. Fatigue and radiotherapy: (A) experience in patients undergoing treatment. Br J Cancer. 1998;78:899–906
  32. Smets EMA, Visser M, Willems-Groot AF, et al. Fatigue and radiotherapy: (B) experience in patients 9 months following treatment. Br J Cancer. 1998;78:907–912
  33. Stone P, Hardy J, Broadley K, et al. Fatigue in advanced cancer: a prospective controlled cross-sectional study. Br J Cancer. 1999;79:1479–1486
  34. Stone P, Hardy J, Huddart R, et al. Fatigue in patients with prostate cancer receiving hormone therapy. Eur J Cancer. 2000;36:1134–1141
  35. Stone P, Richards M, A’Hern R, et al. A study to investigate the prevalence, severity and correlates of fatigue among patients with cancer in comparison with a control group of volunteers without cancer. Ann Oncol. 2000;11:561–567
  36. Stone P, Richards M, A’Hern R, et al. Fatigue in patients with cancers of the breast or prostate undergoing radical radiotherapy. J Pain Symptom Manage. 2001;22:1007–1015
  37. Servaes P, Prins S, Verhagen S, et al. Fatigue after breast cancer and in chronic fatigue syndrome: similarities and differences. J Psychosom Res. 2002;52:453–459
  38. Bruera E, Brenneis C, Paterson AH, et al. Use of methylphenidate as an adjuvant to narcotic analgesics in patients with advanced cancer. J Pain Symptom Manage. 1989;4:3–6
  39. Weitzner MA, Meyers CA, Valentine AD. Methylphenidate in the treatment of neurobehavioral slowing associated with cancer and cancer treatment. Clin Neurosci. 1995;7:347–350
  40. Meyers CA, Weitzner MA, Valentine AD, et al. Methylphenidate therapy improves cognition, mood, and function in brain tumor patients. J Clin Oncol. 1998;16:2522–2527
  41. Breitbart W, Mermelstein H. An alternative psychostimulant for the management of depressive disorders in cancer patients. Psychosomatics. 1992;33:352–356
  42. Schwartz AL, Thompson J, Massood N. Interferon-induced fatigue in patients with melanoma: a pilot study of exercise and methylphenidate. Oncol Nurs Forum. 2002;29:E85–E90
  43. Homsi J, Nelson KA, Sarhill N, et al. A phase II study of methylphenidate for depression in advanced cancer. Am J Hospice Palliative Care. 2001;18:403–407
  44. Sugawara Y, Akechi T, Shima Y, et al. Efficacy of methylphenidate for fatigue in advanced cancer patients: a preliminary study. Palliat Med. 2002;16:261–263
  45. Hanna A, Sledge G, Mayer ML, et al. A phase II study of methylphenidate for the treatment of fatigue. Support Care Cancer. 2006;14:210–215
  46. Bruera E, Driver L, Barnes EA, et al. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report. J Clin Oncol. 2003;21:4439–4443
  47. Marin R. Apathy: concept, syndrome, neural mechanisms, and treatment. Semin Neuropsych. 1996;1:304–314
  48. Popper CW. Pharmacologic alternatives to psychostimulants for the treatment of attention-deficit/hyperactivity disorder. Child Adolesc Psychiatr Clin North Am. 2000;9:605–646
  49. Duffy JD. The neural substrates of motivation. Psychiatric Ann. 1997;27:24–29
  50. Moller H, Berzewski H, Eckmann F, et al. Double-blind multicenter study of paroxetine and amitriptyline in depressed inpatients. Pharmacopsychiatry. 1993;26:75–78
  51. Stuppaeck CH, Geretsegger C, Whitwirth AB, et al. A multicenter double-blind trial of paroxetine versus amitriptyline in depressed inpatients. J Clin Psychopharmacol. 1994;14:241–246
  52. Feighner J, Cohn J, Fabre L, et al. A study comparing paroxetine, placebo, and imipramine in depressed patients. J Affect Disord. 1993;28:71–79
  53. Graci G. Pathogenesis and management of cancer-related insomnia. J Support Oncol. 2005;3:349–359
  54. O’Donnell JF. Insomnia in cancer patients. Clin Cornerstone. 2004;6:S6–S14
  55. Holbrook AM, Crowther R, Lotter A, et al. Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ. 2000;162:225–233
  56. Schmitz KH, Holtzman J, Courneya KS, et al. Controlled physical activity trials in cancer survivors: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev. 2005;14:1588–1595
  57. Knols R, Aaronson NK, Uebelhart D, et al. Physical exercise in cancer patients during and after medical treatment: a systematic review of randomized and controlled clinical trials. J Clin Oncol. 2005;23:3830–3842
  58. Conn VS, Hafdahl A, Porock DC, et al. A meta-analysis of exercise interventions among people treated for cancer. Support Care Cancer. 2006;14:699–712
  59. Jacobsen PB, Meade CD, Stein KD, et al. Efficacy and costs of two forms of stress management training for cancer patients undergoing chemotherapy. J Clin Oncol. 2002;20:2851–2862
  60. Mock V. Evidence-based treatment for cancer-related fatigue. J Natl Cancer Inst Monogr. 2004;32:112–118
  61. Galvao DA, Newton RU. Review of exercise interventions studies in cancer patients. J Clin Oncol. 2005;23:899–909
  62. Segar ML, Katch VL, Roth RS, et al. The effect of aerobic exercise on self-esteem and depressive and anxious symptoms among breast cancer survivors. Oncol Nurs Forum. 1998;25:107–113
  63. Jacobsen PB, Donovan KA, Swaine ZN. Management of Anxiety and Depression in Adult Cancer Patients: Toward an Evidence-Based Approach. New York, NY: Springer-Verlag; 2005;
  64. Barsevick AM, Sweeney C, Haney E, et al. A systematic qualitative analysis of psychoeducational interventions for depression in patients with cancer. Oncol Nurs Forum. 2002;29:73–84
  65. Murtagh DRR, Greenwood KM. Identifying effective psychological treatments for insomnia: a meta-analysis. J Consult Clin Psychol. 1995;63:79–89
  66. Cannici J, Malcolm R, Peek LA. Treatment of insomnia in cancer patients using muscle relaxation training. J Behav Ther Exp Psychiatry. 1983;14:251–256
  67. Stam HJ, Bultz BD. The treatment of severe insomnia in a cancer patient. J Behav Ther Exp Psychiatry. 1986;17:33–37
  68. Simeit R, Deck R, Conta-Marx B. Sleep management training for cancer patients with insomnia. Support Care Cancer. 2004;12:176–183
  69. Davidson JR, Waisberg JL, Brundage MD, et al. Nonpharmacologic group treatment of insomnia: a preliminary study with cancer survivors. Psychooncol. 2001;10:389–397
  70. Quesnel C, Savard J, Simard S, et al. Efficacy of cognitive-behavioral therapy for nonmetastatic breast cancer. J Consult Clin Psychol. 2003;71:189–200

PII: S0749-2081(07)00014-9

doi: 10.1016/j.soncn.2007.01.004

Seminars in Oncology Nursing
Volume 23, Issue 2 , Pages 127-135 , May 2007

Article Tools